NCI Cooperative Groups Begin Trial Of Individualized Rx For Breast Cancer
Surgery Improves Survival For Women With Metastatic Breast Cancer At Diagnosis
Implants Don’t Cause Cancer, Long-Term Study Finds
Immune Systems Don’t Stop, Causing Fatigue For Survivors
Chemo Can Harm Liver, Affect Surgical Outcomes
FEBT, For Pain Control, Shows Positive Results In Phase III
ASCO Releases Guideline On Use Of Growth Factors
Medicare Covers All PET Scans For Cancer In New Program
FDA Approves Medication For Smoking Cessation
NCI-Approved Clinical Trials
Trending Stories
- Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - CBER Director Vinay Prasad dared to “say no to drugs”
- J. Craig Venter’s work was foundational to cancer advancement of the past 25 years
- Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)









